文献速递中药与中成药合理使用

中草药进入欧盟市场的关键质量因素

Key quality factors for Chinese herbal medicines entering the EU market.
PubMed 文献 · Chin Med · 2022-02-22

该综述聚焦中草药进入欧盟市场的质量要求,比较了中国与欧盟的法规和质量控制体系。文章梳理了欧盟药品监管框架、中药材/提取物/产品的关键质量控制因素,并介绍了三种注册路径及中药配方颗粒在欧盟的法律地位,为中药国际化提供参考。

要点

  • 欧盟市场准入需关注药材、提取物和产品三层质量控制差异
  • 中药产品进入欧盟主要有三种注册路径可供选择
  • 中药配方颗粒在欧盟的法律地位是准入讨论要点之一

核心结论

  • 通过比较中欧关键质量因素,明确了双方在质量要求与法规上的异同,为中药进入欧盟市场提供参考。

研究设计与样本

  • 综述类文章,比较中国与欧盟的法规及质量控制要求,未报告系统检索范围与样本量。

主要发现

  • 欧盟药品监管体系及相关法规被梳理,作为中草药质量比较的法规背景。
  • 中药材、提取物和产品的关键质量控制因素在中欧之间进行了对比。
  • 介绍了中药产品进入欧盟的三种主要注册路径,并讨论了中药配方颗粒在欧盟的法律地位。

关键数值与推荐

  • 原文未报告具体质量标准数值、阈值或推荐条款。

临床怎么用

  • 中药研发与注册人员可依据中欧质量要求异同,规划欧盟市场准入的注册路径与质量控制策略。

局限性

  • 原文未报告综述的检索范围、纳入标准及证据等级评价。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Chinese herbal medicines (CHMs) have unique advantages in the prevention and treatment of diseases, which are widely recognized in the world. More and more CHMs are becoming increasingly popular in the international markets. However, the quality control of CHMs is a significant issue for their acceptance and recognition in the international market. This review mainly focuses on the quality requirements for CHMs to enter the European Union (EU) market. Both Chinese and European regulations and quality controls are compared. Firstly, the EU medicinal regulatory system and relevant regulations were reviewed. Secondly, the key factors of the quality control of CHMs, including Chinese herbal drugs, extracts and products were compared with those of European herbal medicines in the EU market. Subsequently, three main registration routes for herbal medicinal products including Chinese herbal medicinal products entering the EU were introduced. Furthermore, the legal status of traditional Chinese medicine granules in the EU was also discussed. Through the comparison of the key quality factors for CHMs in China and the EU, the similarities and differences in terms of quality requirements and regulations are addressed, which provides a reference for the development of CHMs into the EU market.

来源:Chin Med,查看原文。版权归原作者所有。

引用

  1. Wang M, Yao PF, Sun PY, et al. Key quality factors for Chinese herbal medicines entering the EU market. Chin Med. 2022. PMID: 35193628. doi:10.1186/s13020-022-00583-x

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。